These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease. Yang H; Yang H; Xie Z; Wang P; Bi J Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263 [TBL] [Abstract][Full Text] [Related]
6. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. Marr RA; Rockenstein E; Mukherjee A; Kindy MS; Hersh LB; Gage FH; Verma IM; Masliah E J Neurosci; 2003 Mar; 23(6):1992-6. PubMed ID: 12657655 [TBL] [Abstract][Full Text] [Related]
7. Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice. Spencer B; Marr RA; Rockenstein E; Crews L; Adame A; Potkar R; Patrick C; Gage FH; Verma IM; Masliah E BMC Neurosci; 2008 Nov; 9():109. PubMed ID: 19014502 [TBL] [Abstract][Full Text] [Related]
9. Accumulation of murine amyloid-β mimics early Alzheimer's disease. Krohn M; Bracke A; Avchalumov Y; Schumacher T; Hofrichter J; Paarmann K; Fröhlich C; Lange C; Brüning T; von Bohlen Und Halbach O; Pahnke J Brain; 2015 Aug; 138(Pt 8):2370-82. PubMed ID: 25991605 [TBL] [Abstract][Full Text] [Related]
10. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867 [TBL] [Abstract][Full Text] [Related]
11. Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice. Fitz NF; Tapias V; Cronican AA; Castranio EL; Saleem M; Carter AY; Lefterova M; Lefterov I; Koldamova R Brain; 2015 Dec; 138(Pt 12):3699-715. PubMed ID: 26510953 [TBL] [Abstract][Full Text] [Related]
12. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120 [TBL] [Abstract][Full Text] [Related]
14. Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease. El-Amouri SS; Zhu H; Yu J; Marr R; Verma IM; Kindy MS Am J Pathol; 2008 May; 172(5):1342-54. PubMed ID: 18403590 [TBL] [Abstract][Full Text] [Related]
15. BACE/APPV717F double-transgenic mice develop cerebral amyloidosis and inflammation. Ozmen L; Woolley M; Albientz A; Miss MT; Nelboeck P; Malherbe P; Czech C; Gruninger-Leitch F; Brockhaus M; Ballard T; Jacobsen H Neurodegener Dis; 2005; 2(6):284-98. PubMed ID: 16909011 [TBL] [Abstract][Full Text] [Related]
16. Lack of neprilysin suffices to generate murine amyloid-like deposits in the brain and behavioral deficit in vivo. Madani R; Poirier R; Wolfer DP; Welzl H; Groscurth P; Lipp HP; Lu B; El Mouedden M; Mercken M; Nitsch RM; Mohajeri MH J Neurosci Res; 2006 Dec; 84(8):1871-8. PubMed ID: 16998901 [TBL] [Abstract][Full Text] [Related]
17. Cognitive and emotional alterations in App knock-in mouse models of Aβ amyloidosis. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2018 Jul; 19(1):46. PubMed ID: 30055565 [TBL] [Abstract][Full Text] [Related]
18. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice. Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521 [TBL] [Abstract][Full Text] [Related]
19. Aging-related down-regulation of neprilysin, a putative beta-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of beta-amyloid plaques. Apelt J; Ach K; Schliebs R Neurosci Lett; 2003 Mar; 339(3):183-6. PubMed ID: 12633883 [TBL] [Abstract][Full Text] [Related]
20. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease. Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]